Consolidated Statement of Stockholders' Equity (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Jun. 30, 2021	$ 7,580	$ 20,936,050	$ (22,115,408)	$ (1,171,778)
Beginning balance, shares at Jun. 30, 2021	7,579,285
Common stock issued to vendors for compensation	$ 15	162,880		162,895
Common stock issued to vendors for compensation, shares	14,902
Common stock issued for exercise of options	$ 559	1,325,484		$ 1,326,043
Common stock issued for exercise of options, shares	559,775			969,775
Common stock and stock option based compensation expense	$ 11	1,704,342		$ 1,704,353
Stock based compensation expense, shares	10,841
Stock option-based board of directors expense		332,166		332,166
Net loss			(4,983,768)	(4,983,768)
Common stock issued for acquisition	$ 388	3,346,915		3,347,303
Common stock issued for acquisitions, shares	388,342
Common stock issued to satisfy legacy acquisition obligation	$ 453	1,249,547		1,250,000
Common stock issued for legacy acquisition obligation, shares	452,978
Common stock issued in Initial Public Offering, net	$ 1,913	11,819,451		11,821,364
Common stock issued in Initial Public Offering, net, shares	1,912,500
Common stock issued in Securities Purchase Agreement, net	$ 1,500	13,576,900		13,578,400
Common stock issued in Securities Purchase Agreement, net, shares	1,500,000
Common stock issued for convertible note conversion	$ 324	1,605,852		1,606,176
Common stock issued for convertible note conversion, shares	324,150
Ending balance, value at Mar. 31, 2022	$ 12,743	56,059,587	(27,099,176)	28,973,154
Ending balance, shares at Mar. 31, 2022	12,742,773
Beginning balance, value at Dec. 31, 2021	$ 12,480	55,764,735	(25,347,563)	30,429,652
Beginning balance, shares at Dec. 31, 2021	12,480,416
Common stock issued to vendors for compensation	$ 2	14,998		15,000
Common stock issued to vendors for compensation, shares	1,529
Common stock issued for exercise of options	$ 203	712,221		712,424
Common stock issued for exercise of options, shares	202,850
Common stock and stock option based compensation expense		654,090		654,090
Stock option-based board of directors expense		156,298		156,298
Net loss			(1,751,613)	(1,751,613)
Common stock issued for acquisition - fair value adjustment at close		(1,702,697)		(1,702,697)
Common stock issued to satisfy legacy acquisition obligation	$ 58	459,942		460,000
Common stock issued for legacy acquisition obligation, shares	57,978
Ending balance, value at Mar. 31, 2022	$ 12,743	56,059,587	(27,099,176)	28,973,154
Ending balance, shares at Mar. 31, 2022	12,742,773
Beginning balance, value at Jun. 30, 2022	$ 12,749	56,885,815	(28,081,695)	28,816,869
Beginning balance, shares at Jun. 30, 2022	12,747,624
Common stock issued to vendors for compensation	$ 2	5,236		5,238
Common stock issued to vendors for compensation, shares	1,800
Common stock issued for exercise of options	$ 42	66,069		$ 66,111
Common stock issued for exercise of options, shares	41,996			94,932
Common stock issued to satisfy contingent acquisition obligations	$ 469	1,874,605		$ 1,875,074
Common stock issued to satisfy contingent acquisition obligations, shares	469,541
Common stock and stock option based compensation expense	$ 79	2,270,981		2,271,060
Stock based compensation expense, shares	79,167
Stock option-based board of directors expense		379,319		379,319
Net loss			(9,296,960)	(9,296,960)
Common stock issued for acquisition	$ 714	2,845,430		2,846,144
Common stock issued for acquisitions, shares	714,286
Common stock issued for satisfaction of prior year acquisition liability	$ 214	733,822		734,036
Common stock issued for satisfaction of prior year acquisition liability, shares	214,288
Common stock issued for purchase of intangible asset - technology	$ 72	326,364		326,436
Common stock issued for purchase of intangible asset - technology, shares	71,430
Ending balance, value at Mar. 31, 2023	$ 14,341	65,387,641	(37,378,655)	28,023,327
Ending balance, shares at Mar. 31, 2023	14,340,132
Beginning balance, value at Dec. 31, 2022	$ 13,968	63,069,423	(32,156,057)	30,927,334
Beginning balance, shares at Dec. 31, 2022	13,966,007
Common stock issued to vendors for compensation	$ 2	5,236		5,238
Common stock issued to vendors for compensation, shares	1,800
Common stock issued for exercise of options	$ 15	21,180		21,195
Common stock issued for exercise of options, shares	15,315
Common stock issued to satisfy contingent acquisition obligations	$ 326	1,358,678		1,359,004
Common stock issued to satisfy contingent acquisition obligations, shares	326,684
Common stock and stock option based compensation expense	$ 30	847,372		847,402
Stock based compensation expense, shares	30,326
Stock option-based board of directors expense		85,752		85,752
Net loss			(5,222,598)	(5,222,598)
Ending balance, value at Mar. 31, 2023	$ 14,341	$ 65,387,641	$ (37,378,655)	$ 28,023,327
Ending balance, shares at Mar. 31, 2023	14,340,132